Bacterin International Holdings, Inc., Belgrade, MT (NYSE: BONE), a developer of bioactive coatings for medical applications and revolutionary bone graft material, processes and markets innovative, biologic allografts for transplantation. The Company’s biologic scaffolds, OsteoSponge®, OsteoSponge® SC and OsteoWrap®, are made from demineralized bone that is malleable and flexible, which enables more efficient and precise handling. It also markets BacFast® and OsteoLock®, which are used in spine surgery, designed to minimize graft back-out, and increase osteoinductivity. Bacterin's latest allograft, OsteoSelect® DBM Putty has excellent handling characteristics and is distributed as a sterile product, with osteoinductivity testing completed on every lot after terminal sterilization.
Bacterin’s Medical Device and Coatings Division focuses on the development of bioactive coating technologies for implantable devices. It’s core competency is anti-microbial coatings designed to reduce potential infections associated with implants, thus improving rates of healthcare-associated infections and associated costs. This Division also manages surgical kits necessary to support implantation of products processed by Bacterin’s Biologics Division. Headquartered in Belgrade, Montana, Bacterin operates a 32,000 sq. ft., state-of-the-art, fully compliant and FDA registered facility, equipped with five "Class 100" clean rooms.